Koppie T - Search Results

1

A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.

Hernando E, Sarmentero-Estrada J, Koppie T, Belda-Iniesta C, Ramírez de Molina V, Cejas P, Ozu C, Le C, Sánchez JJ, González-Barón M, Koutcher J, Cordón-Cardó C, Bochner BH, Lacal JC, Ramírez de Molina A. Hernando E, et al. Among authors: koppie t. Oncogene. 2009 Jul 2;28(26):2425-35. doi: 10.1038/onc.2009.91. Epub 2009 May 18. Oncogene. 2009. PMID: 19448670 Free PMC article.

2

Prognostic significance of p27Kip1 expression in bladder cancer.

Rabbani F, Koppie TM, Charytonowicz E, Drobnjak M, Bochner BH, Cordon-Cardo C. Rabbani F, et al. BJU Int. 2007 Aug;100(2):259-63. doi: 10.1111/j.1464-410X.2007.06927.x. Epub 2007 Jun 6. BJU Int. 2007. PMID: 17555476

3

Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.

Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH. Koppie TM, et al. Cancer. 2008 Jun;112(11):2384-92. doi: 10.1002/cncr.23462. Cancer. 2008. PMID: 18404699 Free article. Clinical Trial.

4

Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?

Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Koppie TM, et al. Cancer. 2006 Nov 15;107(10):2368-74. doi: 10.1002/cncr.22250. Cancer. 2006. PMID: 17041887 Free article.

5

Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.

Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH. Pettus JA, et al. Eur Urol. 2008 Feb;53(2):370-5. doi: 10.1016/j.eururo.2007.07.031. Epub 2007 Jul 26. Eur Urol. 2008. PMID: 17689003

6

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.

Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS. Apolo AB, et al. Urol Oncol. 2014 Jul;32(5):637-44. doi: 10.1016/j.urolonc.2013.12.012. Epub 2014 May 16. Urol Oncol. 2014. PMID: 24840869 Free PMC article.

7

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH. Dash A, et al. Cancer. 2006 Aug 1;107(3):506-13. doi: 10.1002/cncr.22031. Cancer. 2006. PMID: 16773629 Free article.

8

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.

Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, Bochner BH, Michor F. Riester M, et al. Among authors: koppie t. Clin Cancer Res. 2012 Mar 1;18(5):1323-33. doi: 10.1158/1078-0432.CCR-11-2271. Epub 2012 Jan 6. Clin Cancer Res. 2012. PMID: 22228636 Free PMC article.

9

Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.

Cowan NG, Chen Y, Downs TM, Bochner BH, Apolo AB, Porter MP, La Rochelle JC, Amling CL, Koppie TM. Cowan NG, et al. Among authors: koppie tm. Adv Urol. 2014;2014:746298. doi: 10.1155/2014/746298. Epub 2014 May 28. Adv Urol. 2014. PMID: 24982672 Free PMC article.

10

Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer.

Secin FP, Koppie TM, Salamanca JI, Bokhari S, Raj GV, Olgac S, Serio A, Vickers A, Bochner BH. Secin FP, et al. Int J Urol. 2007 Jan;14(1):26-32. doi: 10.1111/j.1442-2042.2006.01664.x. Int J Urol. 2007. PMID: 17199856 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters